M. Marks

发表

Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases.

R. Jacobs, R. Berkelman, N. MacDonald, 1996, Pediatrics.

Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis

G. Redding, D. Goldmann, B. Ramsey, 1999 .

Therapy for children with invasive pneumococcal infections

B. Schwartz, R. Breiman, R. Jacobs, 1997 .

Acellular pertussis vaccine: recommendations for use as the initial series in infants and children. American Academy of Pediatrics Committee on Infectious Diseases.

B. Schwartz, R. Breiman, R. Jacobs, 1997, Pediatrics.

Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis.

M. Marks, A. Arguedas, M. Zaleska, 1992, American journal of diseases of children.

Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial.

J. Lieberman, M. Marks, H. Stutman, 2002, The Journal of pediatrics.

Erythromycin in treatment of Campylobacter enteritis in children.

C. Pai, E. Tuomanen, M. Marks, 1983, American journal of diseases of children.

Campylobacter gastroenteritis in children.

C. Pai, M. Marks, S. Sorger, 1979, The Journal of pediatrics.

Neurotoxicity of penicillin.

M. Marks, S. Hirshfeld, 1968, The New England journal of medicine.

Treatment of streptococcal pharyngitis. I. Clinical evaluation.

M. Rabinovitch, M. Marks, R. Mackenzie, 1973, Canadian Medical Association journal.

Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections.

M. Marks, T. Eickhoff, E. Cotton, 1971, The Journal of pediatrics.

C. Broome, D. Granoff, R. Jacobs, 1994, Pediatrics.

Soft-tissue infections caused by Mycobacterium fortuitum complex following penetrating injury.

M. Marks, E. K. Subbarao, M. Tarpay, 1987, American journal of diseases of children.

Interaction of ketoconazole with rifampin and isoniazid.

D. Engelhard, M. Marks, H. Stutman, 1984, The New England journal of medicine.

Haemophilus influenzae Infections

M. Marks, 1984, Clinical pediatrics.

American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis.

C. Broome, D. Granoff, R. Jacobs, 1992, Pediatrics.

Ribavirin: adverse drug reactions, 1986 to 1988

M. Marks, M. Zaleska, H. Stutman, 1990, The Pediatric infectious disease journal.

Intradermal Influenza Immunization

M. Marks, J. Eller, 2015 .

Clinical Profile of Pediatric Patients Hospitalized With Respiratory Syncytial Virus Infection

M. Marks, W. V. La Via, H. Stutman, 1993, Clinical pediatrics.

New concepts in viral gastroenteritis

M. Marks, H. Spratt, 2005, Infection.

Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: recommendations for college students). Committee on Infectious Diseases.

S. Dowell, M. Rennels, R. Jacobs, 1996, Pediatrics.

Is Clostridium difficile pathogenic in infants?

M. Marks, D. Welch, 1982, The Journal of pediatrics.

The glomerulopathy of congenital syphilis--an immune deposit disease.

K. Drummond, M. Marks, B. Kaplan, 1972, The Journal of pediatrics.

Infections in bone marrow transplant recipients.

R. Good, D. Engelhard, M. Marks, 1986, The Journal of pediatrics.

5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.

P. Klite, M. Marks, T. Eickhoff, 1972, Annals of internal medicine.

Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.

I. Shalit, M. Marks, S. Chartrand, 1987, The American journal of medicine.

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

M. Marks, K. Desmond, P. Beaudry, 1980, The Journal of pediatrics.

In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum

M. Marks, D. Conrad, R. Scribner, 1985, Antimicrobial Agents and Chemotherapy.

Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn.

L. Wright, A. Fanaroff, W. Oh, 1997, Pediatrics.

Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis.

C. Pai, E. Tuomanen, M. Marks, 1984, The Journal of pediatrics.

Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features.

C. Pai, O. Hammerberg, M. Marks, 1980, The Journal of pediatrics.

"Acne vaccinatum"--a complication of smallpox vaccination.

M. Marks, B. Schmitt, 1971, Pediatrics.

Haemophilus Influenzae Type b Conjugate Vaccines: Recommendations for Immunization With Recently and Previously Licensed Vaccines

C. Broome, D. Granoff, R. Jacobs, 1993, Pediatrics.

Prevalence of Chlamydial antibodies in children.

M. Marks, J. Newton, P. Rettig, 1982, American journal of diseases of children.

Bacterial Meningitis in Children: Diagnosis and Therapy

M. Marks, H. Stutman, 1987, Clinical pediatrics.

American Academy of Pediatrics Committee on Infectious Diseases: The status of acellular pertussis vaccines: current perspective.

J. L. Montagne, A. Hinman, N. MacDonald, 1991, Pediatrics.

VARIABLES INFLUENCING THE IN VITRO SUSCEPTIBILITIES OF HERPES SIMPLEX VIRUSES TO ANTIVIRAL DRUGS

M. Marks, 1974, Pediatric Research.

Meningococcal colonization and infection in children and their household contacts.

C. Frasch, M. Marks, R. Shapera, 1979, American journal of epidemiology.

Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis.

M. Marks, M. Zaleska, H. Stutman, 1993, The Pediatric infectious disease journal.

Pediatrics Chemoprophylaxis Guidelines for Prevention of Group B Streptococcal ( GBS ) Infection by Services

D. Granoff, C. Hall, E. Marcuse, 2006 .

The relationship between pertussis vaccine and central nervous system sequelae: continuing assessment. American Academy of Pediatrics Committee on Infectious Diseases.

R. Yogev, N. Halsey, S. M. Marcy, 1996, Pediatrics.

Infections of the Newborn

M. Marks, 1985 .

American Academy of Pediatrics Committee on Infectious Diseases: The use of oral acyclovir in otherwise healthy children with varicella.

C. Broome, D. Granoff, R. Jacobs, 1993, Pediatrics.

Vitamin A levels in children with measles in Long Beach, California.

M. Marks, A. Arrieta, M. Zaleska, 1992, The Journal of pediatrics.

Exchange transfusion in the treatment of hepatic coma.

S. Mauer, M. Marks, H. Goldman, 1969, The Journal of pediatrics.

Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.

E. Ziegler, L. Corbeil, M. Marks, 1982, The Journal of clinical investigation.

Lethal Haemophilus influenzae type b infection in mice

E. Ziegler, L. Corbeil, M. Marks, 1982, Infection.

Comparative analysis of Haemophilus influenzae type b and Escherichia coli J5 lipopolysaccharides.

K. L. McKinney, M. Marks, M. Hill, 1986, Journal of medical microbiology.

Ringworm resulting from swimming with a polyurethane cast.

M. Marks, R. Gross, A. Guruswamy, 1983, Journal of pediatric orthopedics.

The Exposure of Health Care Workers to Ribavirin Aerosol

M. Marks, H. Stutman, H. Janai, 1989 .

Respiratory syncytial virus infections. An update

M. Marks, 1993 .

Clinical manifestations of coxsackievirus infections in children.

P. Déry, M. Marks, R. Shapera, 1974, American journal of diseases of children.

Respiratory Syncytial Virus Infection: The Expanded Clinical Spectrum

M. Marks, 1993, Clinical pediatrics.

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis.

M. Marks, 1981, The Journal of pediatrics.

Hyperproteinemic Proteinuria Induced by Plasma Infusion

K. Drummond, M. Marks, T. Baliah, 1969, Pediatric Research.

Progressive cough associated with lymphocytic leukemoid reaction in an infant.

M. Marks, H. Krous, T. Stacy, 1980, The Journal of pediatrics.

Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic

J. Waner, J. Christenson, M. Marks, 1987, The Pediatric infectious disease journal.

Invasive Haemophilus influenzae type B infections: a continuing challenge.

M. Marks, H. Stutman, H. Janai, 1990, American journal of infection control.

Common Bacterial Infections in Infancy and Childhood

M. Marks, G. Ahronheim, H. Spratt, 1978, Drugs.

Use of Ribavirin in the Treatment of Respiratory Syncytial Virus Infection

C. Broome, D. Granoff, R. Jacobs, 1993, Pediatrics.

M. Marks, B. Law, Melvin I. Marks, 1985, The Journal of infectious diseases.

Acellular Pertussis Vaccines: Recommendations for Use as the Fourth and Fifth Doses

C. Broome, D. Granoff, R. Jacobs, 1992, Pediatrics.

Upper Respiratory Infections

M. Marks, 1985 .

In Vitro Antibacterial Activity of Amikacin, a New Aminoglycoside, Against Clinical Bacterial Isolates from Children

M. Marks, 1975, Journal of clinical pharmacology.

Haemophilus influenzae type b conjugate vaccines: Recommendations for immunization of infants and children 2 months of age and older: Update

J. L. Montagne, A. Hinman, N. MacDonald, 1991 .

Benign familial hematuria.

K. Drummond, M. Marks, 1969, Pediatrics.

Passive immunization in experimental Herpesvirus hominis infection of newborn mice

M. Marks, F. Luyet, D. Samra, 1975, Infection and immunity.

Pharmacokinetic studies of trimethoprim-sulfamethoxazole in children with gastroenteritis.

B. Hales, A. Neims, M. Marks, 1973, The Journal of infectious diseases.

Penicillin-insensitive pneumococci. Case report and review.

M. Marks, G. Ahronheim, B. Reich, 1979, American journal of diseases of children.

The timing of tuberculin tests in relation to immunization with live viral vaccines.

M. Marks, P. Beaudry, H. Brickman, 1975, Pediatrics.

EVALUATION OF VERTIGO FOLLOWING HEAD INJURIES

M. Marks, S. Baumoel, 1941 .

Respiratory Syncytial Virus Infections

M. Marks, 1992, La Clinica pediatrica.

Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention.

M. Marks, W. V. La Via, H. Stutman, 1992, The Journal of pediatrics.

Exchange transfusion h@atic coma in the treatment of

S. Mauer, M. Marks, H. Goldman, 1969 .

The histochemical nitroblue tetrazolium reduction test in the differential diagnosis of acute infections.

M. Marks, J. Humbert, W. Hathaway, 1971, Pediatrics.

Carbenicillin: a clinical and laboratory evaluation.

M. Marks, T. Eickhoff, 1970, Annals of internal medicine.

The cephalosporins. Are they as important as their numbers suggest?

M. Marks, 1978, American journal of diseases of children.

Ceftriaxone therapy in pediatric patients.

M. Marks, C. Harrison, D. Welch, 1983, American journal of diseases of children.

Synergistic action of amphotericin B and rifampin against Rhizopus species

J. Christenson, I. Shalit, M. Marks, 1987, Antimicrobial Agents and Chemotherapy.

Successful treatment of Candida meningitis with amphotericin B and 5-fluorocytosine in combination.

J. Mulvihill, P. Chesney, M. Marks, 1976, The Journal of pediatrics.

In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097).

M. Marks, T. Eickhoff, P. Steer, 1971, Applied microbiology.

Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine.

M. Marks, T. Eickhoff, 1970, Antimicrobial agents and chemotherapy.

Lower Respiratory Infections

M. Marks, 1985 .

Torulopsis glabrata--an opportunistic pathogen in man.

C. Langston, M. Marks, T. Eickhoff, 1970, The New England journal of medicine.

Laboratory Identification of Torulopsis glabrata: Typical Appearance on Routine Bacteriological Media

M. Marks, E. O'toole, 1970 .

Laboratory identification of Torulopsis glabrata: typical appearance on routine bacteriological media.

M. Marks, E. O'Toole, 1970, Applied microbiology.

Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial.

E. Ayoub, M. Marks, C. Harrison, 1986, Jornal de Pediatria.

Pediatric antimicrobial therapy. VI.

M. Marks, M. Brazeau, R. Shapera, 1973, Canadian Medical Association journal.

Systemic Infections in Normal and Immunocompromised Hosts

M. Marks, 1985 .

Yeast colonization in hospitalized and nonhospitalized children.

M. Marks, S. Marks, M. Brazeau, 1975, The Journal of pediatrics.

In Vitro Susceptibility of Haemophilus influenzae to Sulfamethoxazole-Trimethoprim and Cefaclor, Cephalexin, and Cephradine

C. Pai, M. Marks, R. Sinai, 1978, Antimicrobial Agents and Chemotherapy.

Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis.

E. Tuomanen, A. Smith, Arnold L. Smith, 1981, The Journal of pediatrics.

Model of neonatal meningitis caused by Escherichia coli K1 in guinea pigs.

C. Pai, K. Powell, M. Marks, 1980, The Journal of infectious diseases.

Chloramphenicol in the 1980s

I. Shalit, M. Marks, 1984, Drugs.

Antibiotic therapy of serious Haemophilus infections--a continuing problem.

M. Marks, 1981, The Journal of pediatrics.

Influences of Media and Inocula on the In Vitro Susceptibility of Haemophilus influenzae to Co-Trimoxazole, Ampicillin, Penicillin, and Chloramphenicol

G. Weinmaster, M. Marks, 1975, Antimicrobial Agents and Chemotherapy.

Candida Albicans Infections in Hospitalized Children

M. Marks, P. K. Mazumdar, P. Mazumdar, 1975, Clinical pediatrics.

Is cyclacillin really better?

M. Marks, 1983, The Journal of pediatrics.

Therapy for bacterial meningitis: which drugs, and for how long?

M. Marks, H. Stutman, 1987, The Journal of pediatrics.

Effect of inoculum size on Haemophilus influenzae type b susceptibility to new and conventional antibiotics

M. Marks, D. Welch, C. Laferrière, 1983, Antimicrobial Agents and Chemotherapy.

Bacterial meningitis in infants and children

M. Marks, 1984, Infection.

Screening for Tuberculosis in Infants and Children

D. Granoff, C. Hall, R. Yogev, 1994, Pediatrics.

Chemotherapy for Tuberculosis in Infants and Children

Larry K. Pickering, Melvin I. Marks, S. Plotkin, 1992, Pediatrics.

Pediatric Infectious Diseases for the Practitioner

M. Marks, 1985, Comprehensive Manuals in Pediatrics.

In Vitro Sensitivity of Torulopsis glabrata to Amphotericin B, 5-Fluorocytosine, and Clotrimazole (Bay 5097)

M. Marks, T. Eickhoff, P. Steer, 1971 .

Epiglottitis, Croup, and Laryngitis

M. Marks, M. Muszynski, M. J. Muszynski, 1987 .

Pediatric antimicrobial therapy IV.

M. Marks, M. Brazeau, R. Shapera, 1973, Canadian Medical Association journal.

Common Bacterial Infections in Infancy and Childhood

M. Marks, 2012, Drugs.

Pneumococcal meningitis in children.

R. Laxer, M. Marks, 1977, American journal of diseases of children.

In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound

M. Marks, S. Chartrand, D. Welch, 1983, Antimicrobial Agents and Chemotherapy.

In Vitro Sensitivity of Salmonella to Ten Antimicrobial Agents Including Sulfamethoxazole and Trimethoprim, Alone and in Combination

M. Marks, M. Kazemi, Elaine MacKay, 1973, Antimicrobial Agents and Chemotherapy.

Gianotti disease or Gianotti-Crosti syndrome?

M. Marks, V. S. San Joaquin, 1982, The Journal of pediatrics.

Secondary rates of Haemophilus influenzae type b disease among day care contacts.

M. Marks, W. Dorchester, 1987, The Journal of pediatrics.

Clinical spectrum and carrier state of nontyphoidal salmonella infections in infants and children.

M. Marks, M. Kazemi, G. Gumpert, 1974, Canadian Medical Association journal.

Pharmacokinetics and efficacy of trimethoprim-sulfamethoxazole in the treatment of gastroenteritis in children.

M. Marks, 1975, Canadian Medical Association journal.

A controlled trial comparing sulfametboxazole-trimethoprim, ampicillin, and no therapy in the treatment of salmonella gastroenteritis in children.

M. Marks, M. Kazemi, T. G. Gumpert, 1973, The Journal of pediatrics.

Recurrent herpes simplex.

M. Marks, 1982, Canadian Medical Association journal.

Nosocomial infantile gastroenteritis associated with minirotavirus and calicivirus

C. Pai, M. Marks, P. Gill, 1978, The Journal of Pediatrics.

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis

M. Marks, M. Tarpay, D. Welch, 1982, Antimicrobial Agents and Chemotherapy.

Direct immunofluorescent studies of infection with respiratory syncytial virus.

M. Marks, V. Fulginiti, J. Eller, 1970, The Journal of infectious diseases.

Universal hepatitis B immunization

J. L. Montagne, C. Broome, D. Granoff, 1992 .

In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid

I. Shalit, M. Marks, D. Welch, 1985, Antimicrobial Agents and Chemotherapy.

Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases.

Larry K. Pickering, Noni E. MacDonald, Michael A. Gerber, 1997, Pediatrics.

Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model.

M. Marks, 1975, The Journal of infectious diseases.

Experimental animal model for encephalitis due to herpes simplex virus.

M. Marks, S. Carpenter, M I Marks, 1973, The Journal of infectious diseases.

Evaluation of three antibiotic programs in newborn infants.

M. Marks, C. Dupont, S. Marks, 1978, Canadian Medical Association journal.

Activity of Newer Aminoglycosides and Carbenicillin, Alone and in Combination, Against Gentamicin-Resistant Pseudomonas aeruginosa

M. Marks, S. Hammerberg, G. Greenstone, 1976, Antimicrobial Agents and Chemotherapy.

In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid.

M. Marks, A. Arrieta, A. Arguedas, 1991, The Journal of antimicrobial chemotherapy.

In vitro activity of BMY-28100 against common isolates from pediatric infections

M. Marks, F., Leitner, 1987, Antimicrobial Agents and Chemotherapy.

Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumonia.

M. Marks, D. Welch, R. Scribner, 1985, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis

R. Greenwood, I. Shalit, M. Marks, 1986, Antimicrobial Agents and Chemotherapy.

Oral antibiotic therapy of skeletal infections in children.

H. Owen, M. Marks, G. Ahronheim, 1980, Pediatrics.

Update on timing of hepatitis B vaccination for premature infants and for children with lapsed immunization. American Academy of Pediatrics Committee on Infectious Diseases.

R. Jacobs, C. Hall, R. Berkelman, 1994, Pediatrics.

Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis

M. Marks, H. Stutman, J. C. Akaniro, 1990, Antimicrobial Agents and Chemotherapy.

Leiomyoma presenting as prolonged fever, anemia, and thrombocytosis

G. Humphrey, M. Marks, G. Altshuler, 1983, Cancer.

Common Bacterial Infections in Infancy and Childhood

M. Marks, 1979, Springer Netherlands.

Vitamin A treatment of measles

C. Broome, D. Granoff, R. Jacobs, 1993, Archivos latinoamericanos de nutricion.

Carbenicillin in therapy of systemic infections due to Pseudomonas.

M. Marks, T. Eickhoff, 1970, The Journal of infectious diseases.

Pediatric antimicrobial therapy I.

M. Marks, M. Brazeau, R. Shapera, 1973, Canadian Medical Association journal.

An outbreak of severe pneumonia due to respiratory syncytial virus in isolated Arctic populations.

M. Marks, L. Spence, R. E. Morrell, 1975 .

Rapid identification of herpes simplex virus in tissue culture by direct immunofluorescence.

M. Marks, 1971, The Journal of laboratory and clinical medicine.

Clinico-Pharmacological Studies of Sisomicin in Ill Children

M. Marks, R. Dugal, A. Vose, 1978, Antimicrobial Agents and Chemotherapy.

DIAGNOSTIC USEFULNESS OF THE NITROBLUE TETRAZOLIUM DYE REDUCTION TEST IN A CHILDREN'S HOSPITAL

P. Déry, M. Marks, 1974, Acta Paediatrica Scandinavica.

Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.

M. Marks, K. M. Parker, H. Stutman, 1985, Pediatrics.

Meningococcal disease prevention and control strategies for practice-based physicians. Committee on Infectious Diseases, American Academy of Pediatrics. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

R. Jacobs, C. Hall, R. Berkelman, 1996, Pediatrics.

Recommendations for the use of live attenuated varicella vaccine. American Academy of Pediatrics Committee on Infectious Diseases.

R. Jacobs, C. Hall, R. Berkelman, 1995, Pediatrics.

Cefoperazone pharmacokinetics in acute childhood meningitis.

M. Marks, S. Chartrand, D. Frederick, 1983, The Journal of pediatrics.

Clinical manifestations of Coxsackie virus infections in children.

P. Déry, M. Marks, R. Shapera, 1974 .

Bacterial Meningitis—An Update

M. Marks, 1991, Clinical pediatrics.

Antibiotic Therapy of Fulminant E. coli K1 Sepsis in Infant Rabbits

M. Marks, B. Law, P. Rettig, 1984, Pediatric Research.

Moxalactam therapy of Haemophilus influenzae type b meningitis in children.

M. Marks, S. Chartrand, D. Frederick, 1984, Jornal de Pediatria.

Immunization today--a review.

M. Marks, M. Brazeau, R. Shapera, 1973, Canadian Medical Association journal.

Single-dose pharmacokinetics of aztreonam in pediatric patients

M. Marks, E. Swabb, H. Stutman, 1984, Antimicrobial Agents and Chemotherapy.

Chloramphenicol: properties and clinical use.

M. Marks, C. Laferrière, 1982, Pediatric infectious disease.

Ceftriaxone--and more to come.

M. Marks, 1983, The Journal of pediatrics.

Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis

M. Marks, R. Scribner, A. Weber, 1982, Antimicrobial Agents and Chemotherapy.

Wolman's disease.

A. Márkus, M. Marks, 1968, Canadian Medical Association journal.

Current concepts of smallpox and rubella immunization.

M. Marks, 1972, The Journal of the Maine Medical Association.

Intradermal influenza immunization. Experience with Hong Kong vaccine.

M. Marks, J. Eller, 1971, The American review of respiratory disease.

In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae.

M. Marks, 1975, Canadian Medical Association journal.

Principles of Antibacterial Therapy in Infants and Children

M. Marks, 1979 .

Efficacy of Cold Enrichment Techniques for Recovery of Yersinia enterocolitica from Human Stools

C. Pai, M. Marks, S. Sorger, 1979, Journal of clinical microbiology.

Common Bacterial Infections in Infancy and Childhood

M. Marks, 2012, Drugs.

Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools

C. Pai, M. Marks, S. Sorger, 1979 .

Summary of focused group discussions

M. Marks, 1990 .

Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis.

R. Greenwood, I. Shalit, M. Marks, 1987, The American journal of medicine.

Evaluation of Amoxicillin Therapy in Ill Children

M. Marks, ANN DEWAR Vose, 1978, Journal of clinical pharmacology.

In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin

M. Marks, M. Tarpay, D. Welch, 1982, Antimicrobial Agents and Chemotherapy.

Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin

G. Istre, M. Marks, D. Welch, 1981, Antimicrobial Agents and Chemotherapy.

New applications of old antimicrobials.

M. Marks, 1986, Pediatric annals.

The Long‐Term Prognosis of Aseptic Meningitis in Childhood

M. Reite, C. Seitz, M. Marks, 1970, Developmental medicine and child neurology.

Marks , McLaine , and Drummond TABLE III Clinical and Laboratory Data on Patients with Febrile Proteinuria IUrine Protein Urine Total Serum Case Diagnosis Age Sex Temperature I Concentration

K. Drummond, M. Marks, P. McLaine, 2007 .

Proteinuria in Children with Febrile Illnesses

K. Drummond, M. Marks, P. McLaine, 1970, Archives of disease in childhood.

Diagnosis of bacterial infections of the newborn infant.

M. Marks, D. Welch, 1981, Clinics in perinatology.

Nephropathy and persistent proteinuria after albumin administration in the rat.

K. Drummond, M. Marks, 1970, Laboratory investigation; a journal of technical methods and pathology.

In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients

M. Marks, D. Welch, H. Stutman, 1984, Antimicrobial Agents and Chemotherapy.

Aztreonam therapy for serious gram-negative infections in children.

L. Friedhoff, M. Marks, S. Chartrand, 1986, American journal of diseases of children.

New agents in diarrhea

G. Mccracken, M. Marks, V. S. San Joaquin, 1982, Pediatric infectious disease.

Parainfluenza virus immunofluorescence. In vitro and clinical application of the direct method.

M. Marks, J. Eller, H. Nagahama, 1971, Pediatrics.

Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases.

Larry K. Pickering, Michael A. Gerber, Melvin I. Marks, 1996, Pediatrics.

Susceptibilities of bacteria to different antibiotic regimens. Study in two nursery populations.

P. Déry, M. Marks, E. Mackay, 1975, American journal of diseases of children.

Hemophilus influenzae type b meningitis in infant rabbits. Pathogenesis and therapy.

M. Marks, H. Stutman, V. S. San Joaquin, 1984, American journal of diseases of children.

Skin and Wound Infections

M. Marks, 1979 .

Serum standards for the bioassay of aminoglycosides in cerebrospinal fluid.

M. Marks, R. Sinai, S. Hammerberg, 1978, Journal of clinical pathology.

Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution

M. Marks, M. Tarpay, D. Welch, 1980, Antimicrobial Agents and Chemotherapy.

Update on Tuberculosis Skin Testing of Children

R. Yogev, N. Halsey, S. M. Marcy, 1996, Pediatrics.

Development of Haemophilus influenzae meningitis in patients treated with cefamandole.

M. Marks, S. Chartrand, R. Roberts, 1981, Jornal de Pediatria.

In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum

M. Marks, A. Arguedas, H. Stutman, 1990, Antimicrobial Agents and Chemotherapy.

American Academy of Pediatrics Committee on Infectious Diseases: The relationship between pertussis vaccine and brain damage: reassessment.

J. L. Montagne, A. Hinman, N. MacDonald, 1991, Pediatrics.

Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative study.

M. Marks, L. Chicoine, E. Hillman, 1972, The Journal of pediatrics.

Pasteurella multocida Arthritis and Osteomyelitis

M. Marks, T. Eickhoff, D. B. Bell, 1969 .

Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media.

M. Marks, C. Harrison, D. Welch, 1985, Pediatric infectious disease.

Adverse reactions to 1975 bivalent influenza vaccine in children.

M. Marks, S. Schevill, 1977, Canadian Medical Association journal.

Hemophilus influenzae b meningitis in identical twins of a triplet sibship.

M. Marks, J. Whisnant, D. Coulter, 1974, Pediatrics.

Treatment of infections in patients with cystic fibrosis

M. Marks, 2005, Infection.

Pulmonary infections in patients with cystic fibrosis: where to now?

M. Marks, 1986, The Journal of pediatrics.

Influenza Vaccination in Asthmatic Children on Maintenance Theophylline Therapy

M. Marks, V. S. San Joaquin, S. Reyes, 1982 .

Hydrocarbon pneumonitis.

L. Taussig, M. Marks, N. Eade, 1974, Pediatrics.

Prevalence of Chlamydia trachomatis antibodies in cord blood.

M. Marks, P. Rettig, V. S. San Joaquin, 1981, American journal of obstetrics and gynecology.

Respiratory viruses in cystic fibrosis.

M. Marks, 1984, The New England journal of medicine.

Serial 67Ga-Citrate Imaging During Treatment of Acute Osteomyelitis in Childhood

L. Rosenthall, M. Marks, G. Ahronheim, 1978, Clinical nuclear medicine.

Meningococcal meningitis in children.

M. Marks, A. Vose, J. Ellsworth, 1979, Canadian Medical Association journal.

Yersinia enterocolitica: Comparative In Vitro Activities of Seven New β-Lactam Antibiotics

C. Pai, M. Marks, R. Scribner, 1982, Antimicrobial Agents and Chemotherapy.

Antimicrobial Susceptibilities of Yersinia enterocolitica Biotype 4, Serotype O:3

M. Marks, S. Sorger, S. Hammerberg, 1977, Antimicrobial Agents and Chemotherapy.

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis.

G. Redding, M. Marks, D. Goldmann, 1988, The Journal of pediatrics.

Activities of Various ,-Lactams and Aminoglycosides, Alone and in Combination, Against Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis

M. Marks, M. Tarpay, D. Welch, 2003 .

Pasteurella ureae meningoencephalitis.

C. Pai, M. Marks, S. Sorger, 1978, The Journal of pediatrics.

Enoxacin pharmacokinetics and efficacy in CF-1 mice.

M. Marks, S. Chartrand, J. Dice, 1987, Journal of Antimicrobial Chemotherapy.

Fatal hepatitis in siblings: isolation of coxsackievirus B5 and herpes simplex virus.

S. Mauer, M. Marks, J. Joncas, 1970, Canadian Medical Association journal.

Penicillin prophylaxis in sickle cell disease.

M. Marks, 1984, The Journal of pediatrics.

Antibiotic therapy for bronchopulmonary infections in cystic fibrosis. The American approach.

M. Marks, 1989, Antibiotics and chemotherapy.

Erysipelaslike lesions and hyperesthesia as manifestations of Pseudomonas aeruginosa sepsis.

M. Marks, M. Tarpay, R. Roberts, 1982, JAMA.